Group One Trading’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.6M | Sell |
104,600
-1,200
| -1% | -$394K | 0.06% | 330 |
|
|
2025
Q4 | $37.1M | Buy |
105,800
+2,500
| +2% | +$845K | 0.06% | 293 |
|
|
2025
Q3 | $33.4M | Buy |
103,300
+54,400
| +111% | +$16.9M | 0.06% | 300 |
|
|
2025
Q2 | $19M | Buy |
48,900
+26,200
| +115% | +$10.5M | 0.04% | 456 |
|
|
2025
Q1 | $9.87M | Buy |
22,700
+300
| +1% | +$120K | 0.03% | 630 |
|
|
2024
Q4 | $8.26M | Buy |
22,400
+11,100
| +98% | +$4.64M | 0.02% | 823 |
|
|
2024
Q3 | $5.88M | Buy |
11,300
+3,100
| +38% | +$1.66M | 0.02% | 908 |
|
|
2024
Q2 | $4.44M | Buy |
8,200
+6,600
| +413% | +$3.49M | 0.02% | 877 |
|
|
2024
Q1 | $830K | Sell |
1,600
-5,600
| -78% | -$2.79M | ﹤0.01% | 2254 |
|
|
2023
Q4 | $3.4M | Sell |
7,200
-8,200
| -53% | -$3.79M | 0.01% | 1428 |
|
|
2023
Q3 | $6.71M | Buy |
15,400
+1,800
| +13% | +$816K | 0.02% | 746 |
|
|
2023
Q2 | $6.04M | Buy |
13,600
+4,200
| +45% | +$1.94M | 0.02% | 823 |
|
|
2023
Q1 | $4.32M | Sell |
9,400
-12,300
| -57% | -$5.85M | 0.02% | 925 |
|
|
2022
Q4 | $11.1M | Sell |
21,700
-600
| -3% | -$305K | 0.03% | 679 |
|
|
2022
Q3 | $10.1M | Buy |
22,300
+9,600
| +76% | +$4.59M | 0.02% | 724 |
|
|
2022
Q2 | $6.13M | Sell |
12,700
-2,900
| -19% | -$1.43M | 0.01% | 1153 |
|
|
2022
Q1 | $7.66M | Buy |
15,600
+3,300
| +27% | +$1.51M | 0.01% | 1191 |
|
|
2021
Q4 | $5.7M | Sell |
12,300
-2,100
| -15% | -$883K | ﹤0.01% | 1582 |
|
|
2021
Q3 | $5.37M | Sell |
14,400
-7,100
| -33% | -$2.7M | 0.01% | 1610 |
|
|
2021
Q2 | $8.21M | Sell |
21,500
-18,200
| -46% | -$6.96M | 0.01% | 1234 |
|
|
2021
Q1 | $14.3M | Buy |
39,700
+4,800
| +14% | +$1.54M | 0.02% | 719 |
|
|
2020
Q4 | $11.2M | Buy |
34,900
+1,000
| +3% | +$307K | 0.02% | 745 |
|
|
2020
Q3 | $9.11M | Sell |
33,900
-58,800
| -63% | -$15.8M | 0.03% | 572 |
|
|
2020
Q2 | $24.4M | Buy |
92,700
+44,600
| +93% | +$11.9M | 0.11% | 178 |
|
|
2020
Q1 | $10.9M | Buy |
48,100
+24,500
| +104% | +$6.68M | 0.09% | 233 |
|
|
2019
Q4 | $7.13M | Buy |
23,600
+9,100
| +63% | +$2.5M | 0.05% | 496 |
|
|
2019
Q3 | $3.48M | Sell |
14,500
-18,600
| -56% | -$5.1M | 0.03% | 807 |
|
|
2019
Q2 | $9.34M | Buy |
33,100
+19,100
| +136% | +$5.22M | 0.08% | 249 |
|
|
2019
Q1 | $4.02M | Buy |
14,000
+6,900
| +97% | +$2M | 0.04% | 540 |
|
|
2018
Q4 | $1.86M | Sell |
7,100
-2,400
| -25% | -$660K | 0.02% | 1084 |
|
|
2018
Q3 | $2.6M | Sell |
9,500
-1,200
| -11% | -$312K | 0.02% | 972 |
|
|
2018
Q2 | $2.55M | Buy |
10,700
+7,400
| +224% | +$1.71M | 0.02% | 959 |
|
|
2018
Q1 | $725K | Buy |
+3,300
| New | +$775K | 0.01% | 1752 |
|
|
2017
Q3 | – | Sell |
-1,500
| Closed | -$282K | – | 4902 |
|
|
2017
Q2 | $282K | Sell |
1,500
-100
| -6% | -$18K | ﹤0.01% | 2395 |
|
|
2017
Q1 | $265K | Sell |
1,600
-7,500
| -82% | -$1.19M | ﹤0.01% | 2320 |
|
|
2016
Q4 | $1.31M | Buy |
+9,100
| New | +$1.22M | 0.01% | 1157 |
|
Other funds holding ELV
VCM
VPM
Group One Trading's ELV Position: Q1 2026 in Review
Group One Trading reduced its Elevance Health (ELV) stake by 60% in Q1 2026, selling an estimated $1.32M and leaving 2,707 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.
Group One Trading first reported a position in ELV in Q2 2017 and has held it in 15 quarters since. The position peaked at $20.3M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Group One Trading held 2,707 shares of Elevance Health worth $792K as of Q1 2026.
- Group One Trading sold 4,031 Elevance Health shares in Q1 2026, an estimated $1.32M.
- Elevance Health made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2924 holding.
- Group One Trading first reported a position in Elevance Health in Q2 2017 and has held it in 15 quarters since.
- Group One Trading's Elevance Health position peaked at $20.3M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.